Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID Biosusceptometer

Ashutosh Lal, MD, Roland Fischer, PhD, Elliott Vichinsky, MD UCSF, Marcela Weyhmiller, PhD

Blood (2019) 134 (Supplement_1): 961.

https://doi.org/10.1182/blood-2019-129701

Published: 2019

Journal Articles

Pituitary Iron: Effect on Pituitary Volume and Function in Transfusion Dependent Thalassemia

Sylvia Titi Titi Singer, MD, Roland Fischer, PhD, Qing Yuan, PhD, Ashutosh Lal, MD, Isabel E Allen, PhD, Elliott Vichinsky, MD, Zhiyue J Wang, PhD

Blood (2017) 130 (Supplement 1): 3502.

https://doi.org/10.1182/blood.V130.Suppl_1.3502.3502

Published: 2017

Journal Articles

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Andrea Jarisch, MD, Regine Grosse, MD, Emilia Salzmann-Manrique, Roland Fischer, PhD, Jan Soerensen, MD, Renate Hammerstingl, MD, Eva Rettinger, MD, Andre Manfred Willasch, MD, Thomas Klingebiel, MD, Peter Bader, MD

Blood (2015) 126 (23): 3369.

https://doi.org/10.1182/blood.V126.23.3369.3369

Published: 2015

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

Pituitary Iron and Volume Are Affecting Hormones and Reproductive Potential

Sylvia T Singer, MD, Jerry Wang, MD, Qing Yuan, PhD, Elliott Vichinsky, MD, James Smith, MD, Carole Paley, MD, Roland Fischer, PhD

Blood (2014) 124 (21): 4048.

https://doi.org/10.1182/blood.V124.21.4048.4048

Published: 2014

Journal Articles

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Regine Grosse, MD, Charlotte Pfeiffer, Bjoern P Schoennagel, MD, Gritta E. Janka, MD, PhD, Peter Nielsen, MD, Roland Fischer, PhD, Jin Yamamura, MD

Blood (2013) 122 (21): 2204.

https://doi.org/10.1182/blood.V122.21.2204.2204

Published: 2013

Journal Articles

Determinants Of Tissue Iron Loading In Transfused and Non-Transfused β-Thalassemia and Sickle Cell Disease Patients – Biomarkers Of Iron Regulation and Inflammation

Patrick B Walter, PhD, Zahra Pakbaz, MD, Elizabeta Nemeth, PhD, Tomas Ganz, MD, PhD, John B Porter, MD, Patricia Evans, PhD, Kelsey M Houston, Roland Fischer, PhD, Marcela G Weyhmiller, PhD, Matt Herz, Bs, Jeffery L Miller, MD, Robert Hagar, MD, Lynne D Neumayr, MD, Elliott Vichinsky, MD, Paul Harmatz, MD

Blood (2013) 122 (21): 1017.

https://doi.org/10.1182/blood.V122.21.1017.1017

Published: 2013

Journal Articles

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

John Porter, MD, Patrick B Walter, PhD, Lynne D Neumayr, MD, Patricia Evans, PhD, Marcela G Weyhmiller, PhD, Paul Harmatz, MD, John C. Wood, MD, PhD, Jeffery L Miller, MD, Guenter Weiss, MD, Quing Yuan, PhD, Zhiyue J Wang, PhD, Regine Grosse, MD, Bjoern P Schoennagel, MD, Joerg Meerpohl, MD, Roland Fischer, PhD, Peter Nielsen, MD, Markus Seifert, BSc, Elliott Vichinsky, MD

Blood (2013) 122 (21): 1014.

https://doi.org/10.1182/blood.V122.21.1014.1014

Published: 2013

Journal Articles

Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia

John B. Porter, MD, Patrick B Walter, PhD, Lynne D Neumayr, MD, Patricia Evans, PhD, Marcela G Weyhmiller, PhD, Paul Harmatz, MD, John C Wood, MD, Ph.D, Jeffery L. Miller, Guenter Weiss, MD, Qing Yuan, Zhiyue J Wang, Regine Grosse, MD, Bjoern P Schoennagel, Joerg Meerpohl, Roland Fischer, PhD, Elliott Vichinsky, MD

Blood (2012) 120 (21): 995.

https://doi.org/10.1182/blood.V120.21.995.995

Published: 2012

Journal Articles

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Regine Grosse, MD, Andrea Jarisch, PhD, MD, Jin Yamamura, MD, Peter Nielsen, MD, Roland Fischer, PhD, Gritta Janka, MD, PhD

Blood (2011) 118 (21): 2110.

https://doi.org/10.1182/blood.V118.21.2110.2110

Published: 2011

Journal Articles

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Nicole Jacobi, MD, MS, Regine Grosse, MD, Tugce Aktas, Lena Herich, Peter Nielsen, MD, Roland Fischer, PhD, Tatjana Zabelina, Ulrike Bacher, MD, Nicolaus Kroeger, Sr., MD

Blood (2011) 118 (21): 1018.

https://doi.org/10.1182/blood.V118.21.1018.1018

Published: 2011

Journal Articles

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Regine Grosse, Gritta Janka, MD, PhD, Andrea Jarisch, PhD, MD, Peter Nielsen, Jin Yamamura, Roland Fischer, PhD

Blood (2010) 116 (21): 5168.

https://doi.org/10.1182/blood.V116.21.5168.5168

Published: 2010

Journal Articles

Liver Iron Measurement by SQUID Biosusceptometry Compared to Liver Biopsy: A More Accurate Definition of Optimal Iron Range.

Zahra Pakbaz, MD, Roland Fischer, PhD, Elliott Vichinsky, MD, Robert L. Fagaly, PhD, Douglas Paulson, PhD, Kevin Pratt, John Butz 5, Drucilla Foote, PNP, Keith Quirolo, MD, Paul Harmatz, MD

Blood (2007) 110 (11): 2675.

https://doi.org/10.1182/blood.V110.11.2675.2675

Published: 2007

Journal Articles

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Regine Grosse, MD, Isolde Frieling, MD, Ellen B. Fung, PhD, Achim Wuesthof, MD, Hans P. Kruse, MD, Roland Fischer, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2772.

https://doi.org/10.1182/blood.V110.11.2772.2772

Published: 2007

Journal Articles

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Roland Fischer, PhD, Regine Grosse, Rainer Engelhardt, PhD, Peter Nielsen, PhD, MD, Oliver Leismann, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2776.

https://doi.org/10.1182/blood.V110.11.2776.2776

Published: 2007

Journal Articles

Safety and Efficacy of Peginterferon Alfa-2a and Ribavirin for Hepatitis C in Thalassemia.

Paul Harmatz, MD, Nancy F. Olivieri, MD, Janet Kwiatkowski, MD, Elliott Vichinsky, MD, Patricia Giardina, MD, Farrukh Shah, MD, Elizabeth C. Wright, PhD, Roland Fischer, PhD, Maureen M. Jonas, MD

Blood (2006) 108 (11): 558.

https://doi.org/10.1182/blood.V108.11.558.558

Published: 2006

Journal Articles

Iron Overload in Acute Myelogenous Leukemia after Bone Marrow Transplantation.

Zahra Pakbaz, MD, Roland Fischer, PhD, Nancy Noonan, RN, Sherrie Shiota, PA, Paul Harmatz, MD, Elliott Vichinsky, MD, Mark C. Walters, MD

Blood (2006) 108 (11): 5336.

https://doi.org/10.1182/blood.V108.11.5336.5336

Published: 2006

Journal Articles

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

Regine Grosse, Gisela Janssen, Rainer Engelhardt, Marketa Groeger, Oliver Leismann, Peter Nielsen, Roland Fischer, Gritta Janka

Blood (2006) 108 (11): 1779.

https://doi.org/10.1182/blood.V108.11.1779.1779

Published: 2006

Journal Articles

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

Peter Nielsen, Tim H. Bruemmendorf, Regine Grosse, Rainer Engelhardt, Nicolaus Kroeger, Hartmut Kabisch, Oliver Leismann, Roland Fischer, Axel R. Zander

Blood (2006) 108 (11): 3726.

https://doi.org/10.1182/blood.V108.11.3726.3726

Published: 2006

Journal Articles

MRI Assessment of Pituitary Iron and Volume in Thalassemia, and Relation to Hypothalamic-Pituitary-Gonadal Axis Function (HPG): A Feasibility Study.

Zhiyue J. Wang, PhD, Roland Fischer, PhD, Ellen Butensky, PhD, PNP, Lynne Neumayr, MD, Sylvia Titi Singer, MD, Phillip Lee, MD, Zili Chu, PhD, Jill V. Hunter, MD, John Firebaugh, Elliott Vichinsky, MD, Paul Harmatz, MD

Blood (2006) 108 (11): 1778.

https://doi.org/10.1182/blood.V108.11.1778.1778

Published: 2006

NARROW

Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID Biosusceptometer

Pituitary Iron: Effect on Pituitary Volume and Function in Transfusion Dependent Thalassemia

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Pituitary Iron and Volume Are Affecting Hormones and Reproductive Potential

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Determinants Of Tissue Iron Loading In Transfused and Non-Transfused β-Thalassemia and Sickle Cell Disease Patients – Biomarkers Of Iron Regulation and Inflammation

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Liver Iron Measurement by SQUID Biosusceptometry Compared to Liver Biopsy: A More Accurate Definition of Optimal Iron Range.

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Safety and Efficacy of Peginterferon Alfa-2a and Ribavirin for Hepatitis C in Thalassemia.

Iron Overload in Acute Myelogenous Leukemia after Bone Marrow Transplantation.

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

MRI Assessment of Pituitary Iron and Volume in Thalassemia, and Relation to Hypothalamic-Pituitary-Gonadal Axis Function (HPG): A Feasibility Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only